CVS — An insurance recovery has a measurable test
For CVS, a useful turnaround check is how much of the insurance premium goes back out to pay for medical care.
In its November 4 results, $CVS reported a medical benefit ratio of 91.3% in its Health Care Benefits segment, down from 92.8% a year earlier. The measure compares medical costs with premium revenue.
That means a smaller share of premium revenue was absorbed by medical costs. The remainder still has to cover other expenses; it is not the insurer's net profit margin.
This is a more specific way to examine improvement than simply noticing that earnings rose.
Across CVS, third-quarter revenue was $108.4 billion, up 5.4%, and adjusted earnings were $2.09 a share. Management raised its full-year adjusted earnings forecast to at least $8.20 a share, from a previous range of $7.90 to $8.10.
Adjusted earnings exclude specified items, so the reconciliation to standard accounting results remains part of the research. A higher forecast also does not establish that future medical-cost pressure has disappeared.
The reported insurance ratio gives the recovery argument an operating measure investors can track. The earnings outlook adds management's expectation, but it should not replace that evidence.
Watch the next medical benefit ratio alongside membership, pricing, and management's discussion of care costs. An improvement is more convincing when it persists without relying on a shrinking or unusually favorable pool of business. The task is to test the recovery's source, not just celebrate its headline.